X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (359) 359
Publication (60) 60
Book / eBook (19) 19
Dissertation (10) 10
Book Chapter (4) 4
Book Review (3) 3
Data Set (1) 1
Newspaper Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (157) 157
humans (135) 135
oncology (77) 77
male (75) 75
female (66) 66
cancer (62) 62
middle aged (48) 48
aged (47) 47
article (46) 46
adult (43) 43
animals (41) 41
bladder cancer (36) 36
chemotherapy (36) 36
analysis (32) 32
urology & nephrology (31) 31
care and treatment (29) 29
research (28) 28
aged, 80 and over (27) 27
treatment outcome (26) 26
urology (26) 26
carcinoma (24) 24
urothelial carcinoma (24) 24
urinary bladder neoplasms - pathology (22) 22
metastasis (21) 21
mutation (21) 21
transitional-cell carcinoma (21) 21
urinary bladder neoplasms - drug therapy (21) 21
prognosis (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
carcinoma, transitional cell - drug therapy (18) 18
cisplatin (18) 18
expression (18) 18
health aspects (18) 18
antineoplastic agents - therapeutic use (17) 17
gene expression (17) 17
prostate cancer (17) 17
risk factors (17) 17
urothelial cancer (17) 17
abridged index medicus (16) 16
cisplatin - administration & dosage (16) 16
genetic aspects (16) 16
medical research (16) 16
multidisciplinary sciences (16) 16
studies (16) 16
genomics (15) 15
immunology (15) 15
immunotherapy (15) 15
medical colleges (15) 15
proteins (15) 15
therapy (15) 15
usage (15) 15
biology (14) 14
bladder-cancer (14) 14
neoplasm staging (14) 14
research article (14) 14
retrospective studies (14) 14
survival (14) 14
mice (13) 13
patients (13) 13
tumors (13) 13
urologic neoplasms - drug therapy (13) 13
clinical trials (12) 12
disease-free survival (12) 12
evolution (12) 12
medicine & public health (12) 12
mortality (12) 12
radical cystectomy (12) 12
adolescent (11) 11
bladder (11) 11
diagnosis (11) 11
evolutionary biology (11) 11
genetics & heredity (11) 11
hematology, oncology and palliative medicine (11) 11
medicine (11) 11
microbiology (11) 11
neoplasm invasiveness (11) 11
neoplasm metastasis (11) 11
phase-ii trial (11) 11
science (11) 11
survival rate (11) 11
trial (11) 11
urinary bladder (11) 11
urothelium - pathology (11) 11
biomarkers (10) 10
carcinoma, transitional cell - pathology (10) 10
cystectomy (10) 10
ecology (10) 10
gemcitabine (10) 10
genes (10) 10
genetics (10) 10
genomes (10) 10
kaplan-meier estimate (10) 10
neoadjuvant chemotherapy (10) 10
neoadjuvant therapy (10) 10
pathology (10) 10
adjuvant treatment (9) 9
antineoplastic agents - adverse effects (9) 9
biochemistry & molecular biology (9) 9
cancer therapies (9) 9
combined modality therapy (9) 9
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (6) 6
UTL at Downsview - May be requested (6) 6
UofT at Mississauga - Stacks (3) 3
Gerstein Science - Stacks (2) 2
Robarts - Reference (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
UofT at Scarborough - Stacks (2) 2
Aerospace - Stacks (1) 1
Baycrest Hospital - Wellness Library (1) 1
Earth Sciences (Noranda) - Reference (1) 1
Map & Data - Map Collection (1) 1
OISE - Reference (1) 1
Online Resources - Online (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Regis College - Reference (1) 1
Robarts - Storage (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Thomas Fisher Rare Book - May be requested at Fisher (1) 1
United Church of Canada Archives - Reference (1) 1
University College (Laidlaw) - May be requested in 6-10 wks (1) 1
UofT at Scarborough - Reference (1) 1
Victoria University E.J. Pratt - Reference (1) 1
Victoria University Emmanuel College - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10061, pp. 2796 - 2810
Journal Article
The Lancet Oncology, ISSN 1470-2045, 11/2017, Volume 18, Issue 11, pp. 1483 - 1492
More than half of all patients with advanced urothelial cancer cannot receive standard, first-line cisplatin-based chemotherapy because of renal dysfunction,... 
THERAPY | EFFICACY | ONCOLOGY | SAFETY | RECURRENT | OPEN-LABEL | UNFIT | NIVOLUMAB | BLOCKADE | CARCINOMA | CHEMOTHERAPY | Antimitotic agents | Metastasis | Antineoplastic agents | Cancer | Medical research | Chemotherapy | Comorbidity | Medicine, Experimental
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2011, Volume 29, Issue 12, pp. 1525 - 1530
Journal Article
亚洲男性学杂志:英文版, ISSN 1008-682X, 2014, Volume 16, Issue 3, pp. 359 - 363
Defects within apoptotic pathways have been implicated in prostate cancer (PCa) tumorigenesis, metastatic progression and treatment resistance. A hallmark of... 
细胞凋亡 | 前列腺癌 | 治疗 | 靶点 | 凋亡信号 | 相关蛋白 | 雄激素受体 | 热休克蛋白 | Heat-shock proteins | Ganetespib | Apatorsen | Prostatic neoplasms | Bcl-2 homologous antagonist-killer protein | Custirsen | Apoptosis | Clusterin | clusterin | ANDROGEN RECEPTOR | HSP90 | bcl-2 homologous antagonist-killer protein | ANDROLOGY | apatorsen | STRESS-PROTEINS | apoptosis | ANTISENSE OLIGONUCLEOTIDE | heat-shock proteins | DOCETAXEL | ganetespib | TRIAL | BCL-2 | 90 INHIBITOR | RANDOMIZED PHASE-II | prostatic neoplasms | UROLOGY & NEPHROLOGY | custirsen | EXPRESSION | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Apoptosis - drug effects | Heat-Shock Proteins - metabolism | Humans | Receptors, Androgen - metabolism | Male | Clinical Trials as Topic | Prostatic Neoplasms, Castration-Resistant - drug therapy | Prostatic Neoplasms, Castration-Resistant - metabolism | Prostatic Neoplasms, Castration-Resistant - pathology | Apoptosis Regulatory Proteins - metabolism | Clusterin - metabolism | Signal Transduction - drug effects | HSP90 Heat-Shock Proteins - antagonists & inhibitors | HSP27 Heat-Shock Proteins - metabolism | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Clusterin - antagonists & inhibitors | HSP27 Heat-Shock Proteins - antagonists & inhibitors | Apoptosis - physiology | Prostatic Neoplasms - drug therapy | Proteins | Heat shock proteins | Health aspects | Prostate cancer | Invited Review | apatorsen; apoptosis; bcl-2 homologous antagonist-killer protein; clusterin; custirsen; ganetespib; heat-shock proteins; prostatic neoplasms
Journal Article
Urology Case Reports, ISSN 2214-4420, 07/2017, Volume 13, Issue C, pp. 82 - 84
Port Site Recurrence (PSR) following laparoscopic tumor resections has been reported for a variety of tumors. Though PSR is a rare phenomenon, they most... 
Robotic Laparoscopic Radical Nephroureterectomy | Port site recurrence | Urothelial caricnoma | Sarcomatoid tumor
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2012, Volume 30, Issue 5, pp. 507 - 512
Journal Article
British Journal of Cancer, ISSN 0007-0920, 10/2018, Volume 119, Issue 8, pp. 961 - 970
BACKGROUND: CD24 is a cornerstone of tumour progression in urothelial carcinoma of the bladder (UCB). However, its contribution to cancer stem cell (CSC)-like... 
DIAGNOSIS | METHYLATION | METASTASIS | METAANALYSIS | MANAGEMENT | TUMOR-MARKERS | CISPLATIN | ONCOLOGY | GENE-EXPRESSION | CARCINOMA | PROGRESSION | Urine | Urothelial cancer | Invasiveness | Xenotransplantation | Bladder | Bladder cancer | Polymerase chain reaction | Sensitivity | Stem cells | Xenografts | Biomarkers | Urothelial carcinoma | Tumors | Cancer | Tumour biomarkers | Cancer stem cells
Journal Article